Virus entry as therapeutic target ....................................................................................................... 2
1. Retrovirus ............................................................................................................................ 2
2. HIV replication cyclus ........................................................................................................... 2
2.1 Targeting attachment gp120 to CD4 receptor ........................................................................ 2
2.2 Targeting the binding of gp120 to the co-receptor .................................................................. 3
2.3 Targeting viral & cellular membrane fusion............................................................................ 4
1